Target $7
https://www.benzinga.com/news/21/02/19722492/piper-sandler-initiates-coverage-on-infinity-pharmaceuticals-with-overweight-rating-announces-price
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.